Skip to main content
Top
Published in: BMC Psychiatry 1/2017

Open Access 01-12-2017 | Research article

Do some anxiety disorders belong to the prodrome of bipolar disorder? A clinical study combining retrospective and prospective methods to analyse the relationship between anxiety disorder and bipolar disorder from the perspective of biorhythms

Authors: Na Du, Ya-ling Zhou, Xu Zhang, Jing Guo, Xue-li Sun

Published in: BMC Psychiatry | Issue 1/2017

Login to get access

Abstract

Background

In clinical practice, some patients diagnosed with anxiety disorder (AD) may develop bipolar disorder (BD) many years later, and some cases of AD may be cured by the use of mood stabilizers. However, the relationship between AD and BD should be explored further.

Method

To track how many cases of AD turned to BD and to discover the differences between them, we recruited 48 patients diagnosed with BD, who were assigned to the BD group for the retrospective analysis, and we also recruited 186 patients diagnosed with AD at enrolment; this latter group was asked to complete follow-up surveys conducted 3 months, 6 months, 12 months and 18 months after the primary stage of the study. We defined another two groups according to the usage of mood stabilizers, the rates of reduction in scores on the Hamilton Anxiety Scale and Yale-Brown Obsessive Compulsive Scale, and the changes in Clinical Global Impression scores at different follow-up times: the anxiety group and the atypical BD group (who used mood stabilizers to treat AD). All subjects also completed the NEO Five-Factor Inventory and supplied blood samples to be tested for several endocrine indices (TSH, T3, FT3, T4, FT4, ACTH,PTC) and inflammatory cytokines (IL-6, IL-8, IL-10, TNF-α, CRP) at enrolment.

Results

In total, 14 subjects developed BD by the end of the study. One hundred eleven subjects were included in the anxiety group. Sixty-three subjects were assigned to the atypical BD group, and they had similar features to the 48 subjects in the BD group in terms of personality traits, abnormality rates of endocrine indices and levels of inflammatory cytokines. From the anxiety group to the atypical BD group and then the BD group, the age of first onset gradually decreased, while the frequency of onset and the score of suicidal ideation gradually increased. Furthermore, the atypical BD group showed markedly higher levels of TSH, IL-6, TNF-α and CRP than the other two groups.

Conclusions

Some ADs with unique features might belong to the prodromal stage or the atypical presentation of BD, and recognizing these ADs early will economize many medical resources.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jiang KD, Huang JZ. Bipolar disorder. Beijing: People's Medical Publishing House; 2012. Jiang KD, Huang JZ. Bipolar disorder. Beijing: People's Medical Publishing House; 2012.
2.
go back to reference Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64:53–9.CrossRefPubMed Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64:53–9.CrossRefPubMed
3.
go back to reference Angst J. Epidemiology of the bipolar spectrum. L'Encéphale. 1995;21(6):37–42.PubMed Angst J. Epidemiology of the bipolar spectrum. L'Encéphale. 1995;21(6):37–42.PubMed
4.
go back to reference Czeisler CA, Gooley JJ. Sleep and circadian rhythms in humans. Cold Spring Harb Symp Quant Biol. 2007;72:579–97.CrossRefPubMed Czeisler CA, Gooley JJ. Sleep and circadian rhythms in humans. Cold Spring Harb Symp Quant Biol. 2007;72:579–97.CrossRefPubMed
5.
go back to reference Westrich L, Sprouse J. Circadian rhythm dysregulation in bipolar disorder. Curr Opin Investig Drugs. 2010;11(7):779–87.PubMed Westrich L, Sprouse J. Circadian rhythm dysregulation in bipolar disorder. Curr Opin Investig Drugs. 2010;11(7):779–87.PubMed
6.
go back to reference Abreu T, Braganca M. The bipolarity of light and dark: a review on bipolar disorder and circadian cycles. J Affect Disord. 2015;185:219–29.CrossRefPubMed Abreu T, Braganca M. The bipolarity of light and dark: a review on bipolar disorder and circadian cycles. J Affect Disord. 2015;185:219–29.CrossRefPubMed
7.
go back to reference Hallam KT, Olver JS, Horgan JE, McGrath C, Norman TR. Low doses of lithium carbonate reduce melaton in light sensitivity in healthy volunteers. Int J Neuropsychopharmacol. 2005;8(2):255–9.CrossRefPubMed Hallam KT, Olver JS, Horgan JE, McGrath C, Norman TR. Low doses of lithium carbonate reduce melaton in light sensitivity in healthy volunteers. Int J Neuropsychopharmacol. 2005;8(2):255–9.CrossRefPubMed
8.
go back to reference Leopold K, Ritter P, Correll CU, et al. Risk constellations prior to the development of bipolar disorders: rationale of a new risk assessment tool. J Affect Disord. 2012;136(3):1000–10.CrossRefPubMed Leopold K, Ritter P, Correll CU, et al. Risk constellations prior to the development of bipolar disorders: rationale of a new risk assessment tool. J Affect Disord. 2012;136(3):1000–10.CrossRefPubMed
9.
go back to reference Bechdolf A, Ratheesh A, Wood SJ, et al. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr Pharm Des. 2012;18(4):358–75.CrossRefPubMed Bechdolf A, Ratheesh A, Wood SJ, et al. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr Pharm Des. 2012;18(4):358–75.CrossRefPubMed
10.
go back to reference Geoffroy PA, Leboyer M, Scott J. Predicting bipolar disorder: what can we learn from prospective cohort studies? L'Encéphale. 2015;41(1):10–6.CrossRefPubMed Geoffroy PA, Leboyer M, Scott J. Predicting bipolar disorder: what can we learn from prospective cohort studies? L'Encéphale. 2015;41(1):10–6.CrossRefPubMed
11.
go back to reference Correll CU, Hauser M, Penzner JB, et al. Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode. Bipolar Disord. 2014;16(5):478–92.CrossRefPubMedPubMedCentral Correll CU, Hauser M, Penzner JB, et al. Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode. Bipolar Disord. 2014;16(5):478–92.CrossRefPubMedPubMedCentral
12.
go back to reference Malhi GS, Bargh DM, Coulston CM, Das P, Berk M. Predicting bipolar disorder on the basis of phenomenology: implications for prevention and early intervention. Bipolar Disord. 2014;16(5):455–70.CrossRefPubMed Malhi GS, Bargh DM, Coulston CM, Das P, Berk M. Predicting bipolar disorder on the basis of phenomenology: implications for prevention and early intervention. Bipolar Disord. 2014;16(5):455–70.CrossRefPubMed
13.
go back to reference Zeschel E, Correll CU, Haussleiter IS, et al. The bipolar disorder prodrome revisited: is there a symptomatic pattern? J Affect Disord. 2013;151:551–60.CrossRefPubMed Zeschel E, Correll CU, Haussleiter IS, et al. The bipolar disorder prodrome revisited: is there a symptomatic pattern? J Affect Disord. 2013;151:551–60.CrossRefPubMed
14.
go back to reference Skjelstad DV, Malt UF, Holte A. Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review. J Affect Disord. 2010;126(1–2):1–13.CrossRefPubMed Skjelstad DV, Malt UF, Holte A. Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review. J Affect Disord. 2010;126(1–2):1–13.CrossRefPubMed
15.
go back to reference Katzow JJ, Hsu DJ, Nassir GS. The bipolar spectrum: a clinical perspective. Bipolar Disord. 2003;5(6):436–42.CrossRefPubMed Katzow JJ, Hsu DJ, Nassir GS. The bipolar spectrum: a clinical perspective. Bipolar Disord. 2003;5(6):436–42.CrossRefPubMed
16.
go back to reference Homish GG, Marshall D, Dubovsky S, Leonard KE. Predictors of later bipolar disorder in patients with subthreshold symptoms. J Affect Disord. 2013;144:129–33.CrossRefPubMed Homish GG, Marshall D, Dubovsky S, Leonard KE. Predictors of later bipolar disorder in patients with subthreshold symptoms. J Affect Disord. 2013;144:129–33.CrossRefPubMed
17.
go back to reference Kinley DJ, Walker JR, Enns MW, Sareen J. Panic attacks as a risk for later psychopathology: results from a nationally representative survey. Depress Anxiety. 2011;28:412–9.CrossRefPubMed Kinley DJ, Walker JR, Enns MW, Sareen J. Panic attacks as a risk for later psychopathology: results from a nationally representative survey. Depress Anxiety. 2011;28:412–9.CrossRefPubMed
18.
go back to reference Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao SY. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med. 1997;27:1079–89.CrossRefPubMed Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao SY. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med. 1997;27:1079–89.CrossRefPubMed
19.
go back to reference Mesman E, Nolen WA, Reichart CG, Wals M, Hillegers MHJ. The Dutch bipolar offspring study: 12-year follow-up. Am J Psychiatry. 2013;170:542–9.CrossRefPubMed Mesman E, Nolen WA, Reichart CG, Wals M, Hillegers MHJ. The Dutch bipolar offspring study: 12-year follow-up. Am J Psychiatry. 2013;170:542–9.CrossRefPubMed
20.
go back to reference Johnson JG, Cohen P, Brook JS. Associations between bipolar disorder and other psychiatric disorders during adolescence and early adulthood: a community-based longitudinal investigation. Am J Psychiatry. 2000;157:1679–81.CrossRefPubMed Johnson JG, Cohen P, Brook JS. Associations between bipolar disorder and other psychiatric disorders during adolescence and early adulthood: a community-based longitudinal investigation. Am J Psychiatry. 2000;157:1679–81.CrossRefPubMed
21.
go back to reference Faedda GL, Serra G, Marangoni C, et al. Clinical risk factors for bipolar disorders: a systematic review of prospective studies. J Affect Disord. 2014;168:314–21.CrossRefPubMed Faedda GL, Serra G, Marangoni C, et al. Clinical risk factors for bipolar disorders: a systematic review of prospective studies. J Affect Disord. 2014;168:314–21.CrossRefPubMed
22.
go back to reference Rucklidge JJ. Retrospective parent report of psychiatric histories: do checklists reveal specific prodromal indicators for postpubertal-onset pediatric bipolar disorder? Bipolar Disord. 2008;10:56–66.CrossRefPubMed Rucklidge JJ. Retrospective parent report of psychiatric histories: do checklists reveal specific prodromal indicators for postpubertal-onset pediatric bipolar disorder? Bipolar Disord. 2008;10:56–66.CrossRefPubMed
23.
go back to reference Vodušek VV, Parnas J, Tomori M, Skodlar B. The phenomenology of emotion experience in first-episode psychosis. Psychopathology. 2014;47:252–60.CrossRefPubMed Vodušek VV, Parnas J, Tomori M, Skodlar B. The phenomenology of emotion experience in first-episode psychosis. Psychopathology. 2014;47:252–60.CrossRefPubMed
24.
go back to reference Sun XL. Psychiatry. 3rd ed. Beijing: Higher Education Press; 2008. Sun XL. Psychiatry. 3rd ed. Beijing: Higher Education Press; 2008.
25.
go back to reference Yao RS, Liang LY. Analysis of the application of simplified NEO-FFI to undergraduates. Chin. J Clin Psychol. 2010;18(4):457–9. Yao RS, Liang LY. Analysis of the application of simplified NEO-FFI to undergraduates. Chin. J Clin Psychol. 2010;18(4):457–9.
26.
go back to reference Lawrence A, Pervin, Oliver P, John, Huang XT. Handbook of personality: theory and research. (the 1st version). Shanghai: East China Normal University Press; 2003. Lawrence A, Pervin, Oliver P, John, Huang XT. Handbook of personality: theory and research. (the 1st version). Shanghai: East China Normal University Press; 2003.
27.
go back to reference Howes OD, Falkenberg I. Early detection and intervention in bipolar affective disorder: targeting the development of the disorder. Curr Psychiatry Rep. 2011;13(6):493–504.CrossRefPubMed Howes OD, Falkenberg I. Early detection and intervention in bipolar affective disorder: targeting the development of the disorder. Curr Psychiatry Rep. 2011;13(6):493–504.CrossRefPubMed
28.
go back to reference Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.CrossRefPubMed Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.CrossRefPubMed
29.
go back to reference Swartz CM, Shen WWI. Episodic obsessive compulsive disorder bipolar? A report of four cases. J Affect Disord. 1999;56:61–6.CrossRefPubMed Swartz CM, Shen WWI. Episodic obsessive compulsive disorder bipolar? A report of four cases. J Affect Disord. 1999;56:61–6.CrossRefPubMed
30.
go back to reference Chen XY, Yang DS. The psychological and physiological characteristic of GAD. Chin. J Nerv Ment Dis. 1993;19(2):66–9. Chen XY, Yang DS. The psychological and physiological characteristic of GAD. Chin. J Nerv Ment Dis. 1993;19(2):66–9.
31.
go back to reference Barnett JH, Huang J, Perlis RH, et al. Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med. 2011;41:1593–604.CrossRefPubMed Barnett JH, Huang J, Perlis RH, et al. Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med. 2011;41:1593–604.CrossRefPubMed
32.
go back to reference Chiaroni P, Hantouche EG, Gouvernet J, Azorin JM, Akiskal HS. The cyclothymic temperament in healthy controls and familially at risk individuals for mood disorder: endophenotype for genetic studies? J Affect Disord. 2005;85(1):135–45.CrossRefPubMed Chiaroni P, Hantouche EG, Gouvernet J, Azorin JM, Akiskal HS. The cyclothymic temperament in healthy controls and familially at risk individuals for mood disorder: endophenotype for genetic studies? J Affect Disord. 2005;85(1):135–45.CrossRefPubMed
33.
go back to reference Nowakowska C, Strong CM, Santosa CM, Wang PW, Ketter TA. Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls. J Affect Disord. 2005;85:207–15.CrossRefPubMed Nowakowska C, Strong CM, Santosa CM, Wang PW, Ketter TA. Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls. J Affect Disord. 2005;85:207–15.CrossRefPubMed
34.
go back to reference Galvez JF, Thommi S, Ghaemi SN. Positive aspects of mental illness: a review in bipolar disorder. J Affect Disord. 2011;128:185–90.CrossRefPubMed Galvez JF, Thommi S, Ghaemi SN. Positive aspects of mental illness: a review in bipolar disorder. J Affect Disord. 2011;128:185–90.CrossRefPubMed
35.
go back to reference Gruber J, Culver JL, Johnson SL, Nam JY, Keller KL, Ketter TA. Do positive emotions predict symptomatic change in bipolar disorder? Bipolar Disord. 2009;11(3):330–6.CrossRefPubMedPubMedCentral Gruber J, Culver JL, Johnson SL, Nam JY, Keller KL, Ketter TA. Do positive emotions predict symptomatic change in bipolar disorder? Bipolar Disord. 2009;11(3):330–6.CrossRefPubMedPubMedCentral
36.
go back to reference Bunevicius R, Prange AJ. Thyroid disease and mental disorders: cause and effect or only comorbidity? Curr Opin Psychiatry. 2010;23:363–8.CrossRefPubMed Bunevicius R, Prange AJ. Thyroid disease and mental disorders: cause and effect or only comorbidity? Curr Opin Psychiatry. 2010;23:363–8.CrossRefPubMed
37.
go back to reference Vonk R, Schot van der AC, Kahn RS, Nolen WA, Drexhage HA. Is autoimmune thyroiditis part of the genetic vulnerability (or an Endophenotype) for bipolar disorder? Biol Psychiatry. 2007;62(2):135–40.CrossRefPubMed Vonk R, Schot van der AC, Kahn RS, Nolen WA, Drexhage HA. Is autoimmune thyroiditis part of the genetic vulnerability (or an Endophenotype) for bipolar disorder? Biol Psychiatry. 2007;62(2):135–40.CrossRefPubMed
38.
go back to reference Kellendonk C, Gass P, Kretz O, Schutz G, Tronche F. Corticosteroid receptors in the brain: gene targeting studies. Brain Res Bull. 2002;57:73–83.CrossRefPubMed Kellendonk C, Gass P, Kretz O, Schutz G, Tronche F. Corticosteroid receptors in the brain: gene targeting studies. Brain Res Bull. 2002;57:73–83.CrossRefPubMed
39.
go back to reference Femenía T, Gómez-Galán M, Lindskog M, Magara S. Dysfunctional hippocampal activity affects emotion and cognition in mood disorders. Brain Res. 2012;1476:58–70.CrossRefPubMed Femenía T, Gómez-Galán M, Lindskog M, Magara S. Dysfunctional hippocampal activity affects emotion and cognition in mood disorders. Brain Res. 2012;1476:58–70.CrossRefPubMed
40.
go back to reference Remlinger-Molenda A, Rybakowski J. Neuroimmunology of bipolar affective disorder. Psychiatr Pol. 2010;44(1):27–38.PubMed Remlinger-Molenda A, Rybakowski J. Neuroimmunology of bipolar affective disorder. Psychiatr Pol. 2010;44(1):27–38.PubMed
41.
go back to reference Benker G, Raida M, Olbricht T, Wagner RL, Reinhardt W, Reinwein D. TSH secretion in Cushing’s syndrome: relation to glucocoricoid excess, diabetes, goitre, and the “the sick euthyroid syndrome”. Clin Endocrinol. 1990;33:776–86.CrossRef Benker G, Raida M, Olbricht T, Wagner RL, Reinhardt W, Reinwein D. TSH secretion in Cushing’s syndrome: relation to glucocoricoid excess, diabetes, goitre, and the “the sick euthyroid syndrome”. Clin Endocrinol. 1990;33:776–86.CrossRef
42.
go back to reference Mendonca CA, Vandel S, Bonin B, Bertschy G, Bizouard P. Thyroid function in depressed patients. L'Encéphale. 1996;22(2):85–94. Mendonca CA, Vandel S, Bonin B, Bertschy G, Bizouard P. Thyroid function in depressed patients. L'Encéphale. 1996;22(2):85–94.
43.
go back to reference Lee S, Chow CC, Wing YK, et al. Thyroid function and psychiatric morbidity in patients with manic disorder receiving lithium therapy. J Clin Psychopharmacol. 2000;20(2):204–9.CrossRefPubMed Lee S, Chow CC, Wing YK, et al. Thyroid function and psychiatric morbidity in patients with manic disorder receiving lithium therapy. J Clin Psychopharmacol. 2000;20(2):204–9.CrossRefPubMed
44.
go back to reference Southwick S, Mason JW, Giller EL, Kosten TR. Serum thyroxine change and clinical recovery in psychiatric inpatients. Biol Psychiatry. 1989;25(1):67–74.CrossRefPubMed Southwick S, Mason JW, Giller EL, Kosten TR. Serum thyroxine change and clinical recovery in psychiatric inpatients. Biol Psychiatry. 1989;25(1):67–74.CrossRefPubMed
45.
go back to reference Mantella RC, Butters MA, Amico JA, et al. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology. 2008;33(6):773–81.CrossRefPubMedPubMedCentral Mantella RC, Butters MA, Amico JA, et al. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology. 2008;33(6):773–81.CrossRefPubMedPubMedCentral
46.
go back to reference Lord C, Hall G, Soares CN, Steiner M. Physiological stress response in postpartum women with obsessive-compulsive disorder: a pilot study. Psychoneuroendocrinology. 2011;36(1):133–8.CrossRefPubMed Lord C, Hall G, Soares CN, Steiner M. Physiological stress response in postpartum women with obsessive-compulsive disorder: a pilot study. Psychoneuroendocrinology. 2011;36(1):133–8.CrossRefPubMed
47.
go back to reference Morgado P, Freitas D, Bessa JM, Sousa N, Cerqueira JJ. Perceived stress in obsessive-compulsive disorder is related with obsessive but not compulsive symptoms. Front Psychiatry. 2013;4(21):1–6. Morgado P, Freitas D, Bessa JM, Sousa N, Cerqueira JJ. Perceived stress in obsessive-compulsive disorder is related with obsessive but not compulsive symptoms. Front Psychiatry. 2013;4(21):1–6.
48.
go back to reference Robert KM, Francis EL. Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? Expert Rev Neurother. 2012;12(9):1143–61.CrossRef Robert KM, Francis EL. Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? Expert Rev Neurother. 2012;12(9):1143–61.CrossRef
49.
go back to reference Kimel M, Cifaldi M, Chen N, Revicki DA. Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA. J Rheumatol. 2008;35:206–15.PubMed Kimel M, Cifaldi M, Chen N, Revicki DA. Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA. J Rheumatol. 2008;35:206–15.PubMed
50.
go back to reference Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, et al. Brain derived neurotrophic factor and inflammatory markers in patients with early-vs. late stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12(4):447–58.CrossRefPubMed Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, et al. Brain derived neurotrophic factor and inflammatory markers in patients with early-vs. late stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12(4):447–58.CrossRefPubMed
51.
go back to reference Li SP, Goldman ND. Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements. Biochemistry. 1996;35(28):9060–8.CrossRefPubMed Li SP, Goldman ND. Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements. Biochemistry. 1996;35(28):9060–8.CrossRefPubMed
Metadata
Title
Do some anxiety disorders belong to the prodrome of bipolar disorder? A clinical study combining retrospective and prospective methods to analyse the relationship between anxiety disorder and bipolar disorder from the perspective of biorhythms
Authors
Na Du
Ya-ling Zhou
Xu Zhang
Jing Guo
Xue-li Sun
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2017
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-017-1509-6

Other articles of this Issue 1/2017

BMC Psychiatry 1/2017 Go to the issue